Together We Care: HCP Well-being in Ophthalmology

In this special episode filmed in Paris at EURETINA 2025, I am joined by a very special guest, my fellow Vision Academy and Barometer Program member Prof. Adrian Koh, who is founding partner and senior consultant at the Eye & Retina Surgeons, Camden Medical Centre, Singapore, and Director of Retinal Centre International.Tune in as we dive into the current understanding of the well-being of healthcare professionals (HCPs) working in ophthalmology, and introduce the HCP Barometer Survey, the first comprehensive and holistic analysis of the complexities of HCP well-being in ophthalmology, from professional fulfilment to the impact of clinic capacity constraints.If you are a practicing specialist, fellow, resident, postgraduate, nurse, or technician working in ophthalmology who regularly interacts with and provides care for patients, please click here to complete the survey and tell us about your experiences. If you enjoyed this episode, SUBSCRIBE to “A Chat with Anat” to make sure you never miss an episode! Speaker disclosures:Professor Anat LoewensteinConsultant: 4DMT, AbbVie, Astellas, Aviceda, Bayer, Beyeonics, Boehringer Ingelheim; Eyepoint, NotalVision, Ocular Therapeutix, Oculis, Ocuphire, Opthea, Roche, and Voiant.Professor Adrian KohConsultant: Allergan, Bayer, Carl Zeiss, Heidelberg, Novartis, Topcon.October 2025 | PP-PF-OPHT-ALL-0247-1Further information on topics discussed in this podcast:Ansari AS, et al. Eur J Ophthalmol. 2023;33(4):1640–1649.B Burgos-Blasco, et al. J Fr Ophtalmol. 2022;45(7):689–699.Garrido-Hermosilla AM, et al. Int Ophthalmol. 2024;44(27).Gould LF, et al. Can J  Ophthalmol. 2020;55(3):29–32. Grover R, et al. Ophthalmic Epidemiol. 2021;28:322–329.Palakkamanil MM, et al. Can J Ophthalmol. 2022;57:e103–e106.Patel AJ, et al. Ophthalmol Glaucoma. 2023;6:316–321.Sedhom JA, et al. J Cataract Refract Surg. 2022;48(6):723–729.This podcast series is intended for HCPs, and is not intended for UK audiences. Always refer to local treatment guidelines and relevant prescribing information. Please review the product information before prescribing.This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise.The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer. The activities of the Barometer Program are funded and facilitated by Bayer where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program.The Vision Academy is a group of over 80 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer.